Shaperon And Dong-A ST Sign MOU For Nanobody-Based New Drug Development
10 Jun 2024 //
BUSINESSWIRE
Dong-A ST Signs License-out Deal with Polifarma of Türkiye for NESP®
09 Nov 2022 //
BUSINESSWIRE
Dong-A ST and Beactica mutually agree to conclude oncology collaboration
06 Sep 2022 //
PRNEWSWIRE
Dong-A ST with Beactica to develop new cancer treatments
03 Dec 2019 //
BIOSPECTRUM ASIA
Dong-A ST and Beactica Expand Their Research and Licence Agreement
12 Mar 2019 //
PR NEWSWIRE
Kaken signs agreement with Korea’s Dong-A ST for Clenafin/Jublia
01 Jun 2016 //
BIOSPECTRUM ASIA